within Pharmacolibrary.Drugs.ATC.J;

model J07CA13
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 0 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 0.5 / 1000000,
    adminCount     = 1,
    Vd             = 0,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Combined vaccine for immunization against diphtheria, Haemophilus influenzae type B, pertussis (whooping cough), tetanus, hepatitis B, and meningococcal groups A and C. Used primarily in pediatric immunization schedules to protect against these infectious diseases. Such combination vaccines are approved in some countries to reduce the number of injections and improve compliance.</p><h4>Pharmacokinetics</h4><p>No published pharmacokinetic models or quantitative PK parameters found; combination vaccines work primarily by inducing immune response and pharmacokinetics are not typically reported for their antigenic components.</p><h4>References</h4><ol></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end J07CA13;
